 Mice, Inbred BALB C
"Mice, Inbred BALB C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.
| Descriptor ID |
D008807
|
| MeSH Number(s) |
B01.050.050.199.520.520.338 B01.050.150.900.649.313.992.635.505.500.400.338
|
| Concept/Terms |
Mice, Inbred BALB C- Mice, Inbred BALB C
- BALB C Mouse, Inbred
- Inbred BALB C Mice
- Mouse, BALB C
- BALB C Mouse
- Mouse, Inbred BALB C
- Mice, BALB C
- BALB C Mice
- BALB C Mice, Inbred
- Inbred BALB C Mouse
|
Below are MeSH descriptors whose meaning is more general than "Mice, Inbred BALB C".
Below are MeSH descriptors whose meaning is more specific than "Mice, Inbred BALB C".
This graph shows the total number of publications written about "Mice, Inbred BALB C" by people in this website by year, and whether "Mice, Inbred BALB C" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 15 | 15 | | 1997 | 0 | 9 | 9 | | 1998 | 0 | 13 | 13 | | 1999 | 0 | 13 | 13 | | 2000 | 0 | 18 | 18 | | 2001 | 0 | 23 | 23 | | 2002 | 0 | 30 | 30 | | 2003 | 0 | 34 | 34 | | 2004 | 0 | 35 | 35 | | 2005 | 0 | 30 | 30 | | 2006 | 0 | 38 | 38 | | 2007 | 0 | 34 | 34 | | 2008 | 0 | 44 | 44 | | 2009 | 0 | 46 | 46 | | 2010 | 0 | 27 | 27 | | 2011 | 1 | 38 | 39 | | 2012 | 0 | 29 | 29 | | 2013 | 0 | 36 | 36 | | 2014 | 0 | 29 | 29 | | 2015 | 0 | 31 | 31 | | 2016 | 0 | 24 | 24 | | 2017 | 0 | 28 | 28 | | 2018 | 0 | 31 | 31 | | 2019 | 0 | 37 | 37 | | 2020 | 0 | 22 | 22 | | 2021 | 0 | 29 | 29 | | 2022 | 0 | 8 | 8 | | 2023 | 0 | 6 | 6 | | 2024 | 4 | 4 | 8 | | 2025 | 0 | 9 | 9 | | 2026 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mice, Inbred BALB C" by people in Profiles.
-
Sordello S, Brock L, Tagliavini A, Federico D, Boulenc X, Pergher M, Huc Claustre E, Metcalf D, Walter ND, Robertson GT, Clary J, Berg A, Mdluli K, Hermann D, Flood D, Upton AM. A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model. Antimicrob Agents Chemother. 2026 Feb 04; 70(2):e0110925.
-
Muthuraman K, Jackman M, Liang Y, Garrett ME, Cui H, Nguyen LVH, Ivanochko D, Ye C, Pino PA, Hicks A, Maingot B, Yusko E, Benzeno S, Martínez-Sobrido L, Torrelles JB, Gilbert AE, Rubin BER, Keitany G, Jetha A, Julien J-P. Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions. J Virol. 2025 12 23; 99(12):e0152325.
-
Lentz RW, Lang J, Pitts TM, Blatchford P, Hu J, Jordan KR, Van Bokhoven A, Bagby SM, Dominguez ATA, Binns CA, Robinson HR, Balmaceda N, Baiyee E, Leal AD, Kim SS, Davis SL, Lieu CH, Wadlow RC, Spencer K, Scott AJ, Boland PM, Hochster HS, Messersmith WA. Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer. Cancer Res Commun. 2025 Nov 01; 5(11):2039-2052.
-
Barnes A, Gaikwad HK, Siegel D, Angarita D, Nebbia M, Anchordoquy T, Bourne D, Stewart M, Yildirim A, Fierro Cota MM, Duffy JT, Haupt BE, Balyasnikova IV, Simberg D. Role of Serum Stability and Lipoprotein Interactions in Lipid Structure-Tumor Accumulation Relationship. ACS Nano. 2025 Oct 21; 19(41):36435-36450.
-
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Hendrix J, Voskuil MI, Obregón-Henao A, Lyons MA, Robertson GT, Moore CM, Walter ND. Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo. Antimicrob Agents Chemother. 2025 Nov 05; 69(11):e0049225.
-
Randolph T, Coleman H, Rauch AM, Hubert H, Witeof AE, Walker KD, Funke HH, Garcea RL. Superior immune responses from thermostable, single-administration rabies vaccines prepared using atomic layer deposition. J Pharm Sci. 2025 Sep; 114(9):103936.
-
Saisuwan K, Boonnate P, Goto H, Nakagawa R, Abe M, Hirabayashi K, Fujiwara Y, Kikuta K, Okada S. Establishment and characterization of TK-DDCS1: a novel IDH1 mutated dedifferentiated chondrosarcoma cell line. Hum Cell. 2025 Jun 03; 38(4):116.
-
Drake LY, Stelzig KE, Hernandez-Botero AM, Berdnikovs S, Chiarella SE. Sex Differences in Lung B Cell Responses in a Murine Model of Asthma. Int Arch Allergy Immunol. 2026; 187(1):74-85.
-
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Ektnitphong V, Bauman AA, Massoudi LM, Voskuil MI, Robertson GT, Moore CM, Walter ND. Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice. Antimicrob Agents Chemother. 2025 02 13; 69(2):e0131024.
-
Ishiguro T, Takeda K, Takayanagi D, Mura E, Suzuki R, Tsurui T, Iriguchi N, Hirasawa Y, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Izumizaki M, Wada S, Yoshimura K, Hoffman RM, Tsunoda T. Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors. Cancer Genomics Proteomics. 2025 Jan-Feb; 22(1):1-12.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|